The Changing Microbial Epidemiology in Cystic Fibrosis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Microbiology Reviews

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1128/CMR.00068-09PMID 20375354PMCID PMC2863368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trends in the use of routine therapies in cystic fibrosis: 1995–2005

  2010cited by this paper
• Mucoid Inquilinus limosus in a young adult with cystic fibrosis

  2009influential reference
• Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.

  2009cited by this paper
• Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.

  2009cited by this paper
• Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review.

  2009influential reference
• Molecular Characterization of Stenotrophomonas maltophilia Isolates from Cystic Fibrosis Patients and the Hospital Environment

  2009cited by this paper
• Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

  2009cited by this paper
• Eradication of early Pseudomonas infection in cystic fibrosis

  2009cited by this paper
• Emergence of SCCmec Type IV as the Most Common Type of Methicillin-Resistant Staphylococcus aureus in a University Hospital

  2009cited by this paper
• Burkholderia cepacia Complex: Impact on the Cystic Fibrosis Lung Lesion

  2009cited by this paper
• Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.

  2009influential reference
• Prevalence of Community-Associated Methicillin-Resistant Staphylococcus aureus in Patients with Cystic Fibrosis

  2009cited by this paper
• Growing old with cystic fibrosis - the characteristics of long-term survivors of cystic fibrosis.

  2009cited by this paper
• Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.

  2009cited by this paper
• Genetic Diversity and Multihost Pathogenicity of Clinical and Environmental Strains of Burkholderia cenocepacia

  2009cited by this paper
• Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.

  2009cited by this paper
• Expanded Multilocus Sequence Typing for Burkholderia Species

  2009cited by this paper
• Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report.

  2008cited by this paper
• Development of a novel PCR assay for the identification of the black yeast, Exophiala (Wangiella) dermatitidis from adult patients with cystic fibrosis (CF).

  2008cited by this paper
• Inquilinus limosus and Cystic Fibrosis

  2008influential reference
• Diagnosis and Treatment of Infections due to Mycobacterium avium Complex

  2008cited by this paper
• Infection in solid-organ transplant recipients.

  2008cited by this paper
• The role of respiratory viruses in cystic fibrosis

  2008cited by this paper
• Recovery of Herbaspirillum Species from Persons with Cystic Fibrosis

  2008cited by this paper
• The Streptococcus milleri group—An unrecognized cause of disease in cystic fibrosis: A case series and literature review

  2008cited by this paper
• Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.

  2008cited by this paper
• Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Nonfermenting Gram-Negative Bacilli Isolated from Cystic Fibrosis Patients

  2008influential reference
• Complex molecular epidemiology of methicillin-resistant staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus.

  2008cited by this paper
• Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005.

  2008influential reference
• Risk factors and outcome

  2008cited by this paper
• Prevalence and Impact of Respiratory Viral Infections in Young Children With Cystic Fibrosis: Prospective Cohort Study

  2008cited by this paper
• Development of an Oligonucleotide Array for Direct Detection of Fungi in Sputum Samples from Patients with Cystic Fibrosis

  2008cited by this paper
• Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients  

  2008cited by this paper
• Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

  2008cited by this paper
• A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

  2008cited by this paper
• Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex.

  2008cited by this paper
• Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis.

  2008cited by this paper
• Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients

  2008cited by this paper
• Selective Isolation of Pseudallescheria and Scedosporium Species from Respiratory Tract Specimens of Cystic Fibrosis Patients

  2008cited by this paper
• [Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study].

  2008cited by this paper
• Outbreak of Burkholderia cepacia Bacteremia Caused by Contaminated Chlorhexidine in a Hemodialysis Unit

  2008cited by this paper
• Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel

  2008cited by this paper
• High-resolution genotyping of Aspergillus fumigatus isolates recovered from chronically colonised patients with cystic fibrosis

  2008cited by this paper
• Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States

  2008cited by this paper
• Patient registry analyses: seize the data, but caveat lector.

  2008cited by this paper
• Update on the epidemiology and management of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, in patients with cystic fibrosis

  2007cited by this paper
• Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.

  2007cited by this paper
• Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods

  2007cited by this paper
• Multistate outbreak of Burkholderia cenocepacia colonization and infection associated with the use of intrinsically contaminated alcohol-free mouthwash.

  2007cited by this paper
• First Isolations of Segniliparus rugosus from Patients with Cystic Fibrosis

  2007cited by this paper
• Transmission of Panton-Valentine leukocidin-positive Staphylococcus aureus between patients with cystic fibrosis.

  2007cited by this paper
• Emerging and unusual gram-negative infections in cystic fibrosis.

  2007cited by this paper
• Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.

  2007cited by this paper
• Molecular Epidemiology of Mycobacterium abscessus, with Focus on Cystic Fibrosis

  2007cited by this paper
• Aspergillus infection in lung transplant patients: incidence and prognosis

  2007influential reference
• Environmental Burkholderia cepacia Complex Isolates from Human Infections

  2007cited by this paper
• Fungal infections in patients with cystic fibrosis

  2007cited by this paper
• Community-associated Methicillin-resistant Staphylococcus aureus Isolates and Healthcare-Associated Infections

  2007cited by this paper
• Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

  2007cited by this paper
• Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis.

  2007cited by this paper
• Potential role of the cellular allergen stimulation test (CAST) in diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis

  2007cited by this paper
• Molecular and Phenotypic Data Supporting Distinct Species Statuses for Scedosporium apiospermum and Pseudallescheria boydii and the Proposed New Species Scedosporium dehoogii

  2007cited by this paper
• RSV Mediates Pseudomonas aeruginosa Binding to Cystic Fibrosis and Normal Epithelial Cells

  2007cited by this paper
• Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis

  2007cited by this paper
• Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

  2007cited by this paper
• An outbreak of Burkholderia cepacia associated with contamination of albuterol and nasal spray.

  2006cited by this paper
• Methicillin-resistant S. aureus infections among patients in the emergency department.

  2006cited by this paper
• Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis

  2006cited by this paper
• Chronic Colonization with Pandoraea apista in Cystic Fibrosis Patients Determined by Repetitive-Element-Sequence PCR

  2006cited by this paper
• Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis

  2006cited by this paper
• Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic

  2006cited by this paper
• Compliance of Clinical Microbiology Laboratories in the United States with Current Recommendations for Processing Respiratory Tract Specimens from Patients with Cystic Fibrosis

  2006cited by this paper
• Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist.

  2006cited by this paper
• Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study.

  2006cited by this paper
• Simultaneous coinfection by multiple strains during Burkholderia cepacia complex infection in cystic fibrosis.

  2006cited by this paper
• Characterization of a Strain of Community-AssociatedMethicillin-Resistant Staphylococcus aureus WidelyDisseminated in the UnitedStates

  2006cited by this paper
• Clonal analysis of Inquilinus limosus isolates from six cystic fibrosis patients and specific serum antibody response.

  2006influential reference
• Early-onset prosthetic valve endocarditis caused by Inquilinus sp.

  2006cited by this paper
• Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection

  2006cited by this paper
• Staphylococcal Cassette Chromosome mec and Panton-Valentine Leukocidin Characterization of Methicillin-Resistant Staphylococcus aureus Clones

  2006cited by this paper
• Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002.

  2006cited by this paper
• The General Secretory Pathway of Burkholderia gladioli pv. agaricicola BG164R Is Necessary for Cavity Disease in White Button Mushrooms

  2006cited by this paper
• High Pseudomonas aeruginosa acquisition rate in CF

  2006cited by this paper
• Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis.

  2006cited by this paper
• Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes.

  2005cited by this paper
• Age-Related Prevalence and Distribution of Nontuberculous Mycobacterial Species among Patients with Cystic Fibrosis

  2005cited by this paper
• Distribution of Burkholderia cepacia Complex Species among Isolates Recovered from Persons with or without Cystic Fibrosis

  2005cited by this paper
• Clinical and Microbiological Features of Inquilinus sp. Isolates from Five Patients with Cystic Fibrosis

  2005influential reference
• Shared Genotypes of Achromobacter xylosoxidans Strains Isolated from Patients at a Cystic Fibrosis Rehabilitation Center

  2005cited by this paper
• Inquilinus limosus in Patients with Cystic Fibrosis, Germany

  2005influential reference
• Nontuberculous mycobacterial infection in young children with cystic fibrosis

  2005cited by this paper
• Prospective evaluation of emerging bacteria in cystic fibrosis.

  2005cited by this paper
• Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.

  2005cited by this paper
• Viral respiratory infections in cystic fibrosis

  2005cited by this paper
• Bacterial activity in cystic fibrosis lung infections

  2005cited by this paper
• Multilocus Sequence Typing Scheme That Provides Both Species and Strain Differentiation for the Burkholderia cepacia Complex

  2005cited by this paper
• Staphylococcus aureus Isolates Carrying Panton-Valentine Leucocidin Genes in England and Wales: Frequency, Characterization, and Association with Clinical Disease

  2005cited by this paper
• Update on the Burkholderia cepacia complex

  2005cited by this paper
• Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy

  2005cited by this paper
• Transmission of Burkholderia cepacia Complex: Evidence for New Epidemic Clones Infecting Cystic Fibrosis Patients in Italy

  2005cited by this paper

• Interkingdom signaling elicited by bacterial extracellular vesicles in human cystic fibrosis airway epithelium and neutrophils

  2026cites this paper
• Streptococcus sanguinis antagonizes Prevotella melaninogenica in the context of the cystic fibrosis respiratory microbiome

  2026cites this paper
• Antibiotic susceptibility testing of Burkholderia cepacia complex isolates: an evidence-based guide for clinics

  2026cites this paper
• Current knowledge and perspectives on the emerging Inquilinus limosus pathogen

  2026cites this paper
• Non-viral mRNA cystic fibrosis therapies and their ongoing clinical trials

  2025cites this paper
• Isolation and Characterization of Four New Coliphages against Extra Intestinal Pathogenic Escherichia coli Isolates Recovered from Cystic Fibrosis Patients

  2025cites this paper
• Time sequence of bacterial and fungal pathogens causing infections in trauma patients

  2025cites this paper
• Haemophilus influenzae in bronchiectasis

  2025cites this paper
• Catalytic activity of the prepilin peptidase PilD is required for full P. aeruginosa virulence in a nematode infection model

  2025cites this paper
• Dynamic balance of the lung microbiome in health and respiratory diseases.

  2025cites this paper
• CFTR mutation leads to intrinsic dysfunction in neutrophils from people with Cystic Fibrosis

  2025cites this paper
• Dual RNA sequencing of a co-culture model of Pseudomonas aeruginosa and human 2D upper airway organoids

  2025cites this paper
• Exploring the role of microbiome in cystic fibrosis clinical outcomes through a mediation analysis

  2025cites this paper
• Insights on the Pathogenesis of Mycobacterium abscessus Infection in Patients with Cystic Fibrosis

  2025cites this paper
• Pathogenic profiles and lower respiratory tract microbiota in severe pneumonia patients using metagenomic next-generation sequencing

  2025cites this paper
• Mutation characterisation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in people with cystic fibrosis in Northern Ireland

  2025cites this paper
• Development of spray-dried phage-aztreonam microparticles for inhalation therapy of Pseudomonas aeruginosa lung infections.

  2025cites this paper
• Impact of Antibiotic Therapy on the Upper Respiratory Tract and Gut Mycobiome in Patients with Cystic Fibrosis

  2025cites this paper
• Doxycycline Versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus Aureus-Associated Acute Pulmonary Exacerbations in People With Cystic Fibrosis

  2025cites this paper
• Phylogeny, Synteny, and Distribution of Type III Secretion Systems in Burkholderia cenocepacia: A Closer Look Into Host Span

  2025cites this paper
• Comparative genomic analyses shed light on the introduction routes of rice-pathogenic Burkholderia gladioli strains into Bangladesh

  2025cites this paper
• Ecological Diversity, Metabolic Versatility, and Biotechnological Applications of Burkholderia Species: An Overview

  2025cites this paper
• Dual-action thioarylamide-based small molecules to target drug-resistant bacteria and chronic inflammation

  2025cites this paper
• A SIMPL Model of Phage-Bacteria Interactions Accounting for Mutation and Competition

  2025cites this paper
• Microbiota, Mucus, and Modulators: CF Infection Pathogenesis in the CFTR Modulator Era.

  2025cites this paper
• Necrotizing pneumonia and septic shock caused by Burkholderia cepacia in an immunocompetent adult

  2025cites this paper
• Antibacterial Siderophores of Pandoraea Pathogens and Their Impact on the Diseased Lung Microbiota

  2025cites this paper
• Genomic insights and phenotypic characterisation of three multidrug resistant Cupriavidus strains from the cystic fibrosis lung.

  2025cites this paper
• Clinical Disorders in Cystic Fibrosis That Affect Emergency Procedures—A Case Report and Review

  2025cites this paper
• In vitro untargeted polar metabolomics data from B. cenocepacia and S. aureus biofilm supernatants

  2025cites this paper
• STAT3-dependent Regulation of CFTR and Ciliogenesis Is Essential for Mucociliary Clearance and Innate Airway Defense in Hyper-IgE Syndrome.

  2025cites this paper
• Inquilinus Species Infections in Humans—A Narrative Review

  2025cites this paper
• The Increased Risk for Postinfluenza Pneumonia Among Cystic Fibrosis Carriers—A Population-Based Study

  2025cites this paper
• The secretome of the environmental bacterium Pseudomonas protegens PBL3 has broad-spectrum antimicrobial activity against plant and human pathogenic bacteria

  2025cites this paper
• Repurposing High-Throughput Screening Reveals Unconventional Drugs with Antimicrobial and Antibiofilm Potential Against Methicillin-Resistant Staphylococcus aureus from a Cystic Fibrosis Patient

  2025cites this paper
• Colony morphotype variation in Burkholderia: implications for success of applications and therapeutics

  2025cites this paper
• Bacterial Diversity of Green Turtle Eggs and Nest Sand on Samandağ Beach

  2025cites this paper
• Complete genome sequence of the biopesticidal Burkholderia ambifaria strain BCC0191

  2024cites this paper
• Lung microbiome: new insights into the pathogenesis of respiratory diseases

  2024cites this paper
• Clinical epidemiology and impact of Haemophilus influenzae airway infections in adults with cystic fibrosis

  2024cites this paper
• Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis

  2024cites this paper
• Prophylactic phage biocontrol prevents Burkholderia gladioli infection in a quantitative ex planta model of bacterial virulence

  2024cites this paper
• Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response

  2024cites this paper
• A crucial role of neutrophil extracellular traps in pulmonary infectious diseases

  2024cites this paper
• The clinical, microbiological, and demographic aspects of Burkholderia infections: insights from a tertiary healthcare setting

  2024cites this paper
• Burkholderia cenocepacia ST-250 in cystic fibrosis patients in Switzerland: Genomic investigation of transmission routes.

  2024cites this paper
• Evaluation of CHROMagar™ B. cepacia agar for the detection of Burkholderia cepacia complex species from sputum samples of patients with cystic fibrosis

  2024cites this paper
• The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection.

  2024cites this paper
• Novel Ralstonia species from human infections: improved matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based identification and analysis of antimicrobial resistance patterns

  2024cites this paper
• Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients.

  2024cites this paper
• 40-year single center experience of Burkholderia cystic fibrosis airway infections.

  2024cites this paper
• Ceragenin-mediated disruption of Pseudomonas aeruginosa biofilms

  2024cites this paper
• Periodontal disease prevalence and oral hygiene status of adults with cystic fibrosis: A case-control study.

  2024cites this paper
• Pseudomonas aeruginosa transcriptome analysis of metal restriction in ex vivo cystic fibrosis sputum

  2024cites this paper
• Pulmonary Bacterial Pathogens in Patients with Cystic Fibrosis

  2024cites this paper
• Dpr-mediated H2O2 resistance contributes to streptococcus survival in a cystic fibrosis airway model system

  2024cites this paper
• In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain.

  2024cites this paper
• Interspecies interactions alter the antibiotic sensitivity of Pseudomonas aeruginosa

  2024cites this paper
• Mechanisms of Staphylococcus aureus survival of trimethoprim-sulfamethoxazole-induced thymineless death

  2024cites this paper
• Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM).

  2024cites this paper
• Burkholderia pseudomallei Complex Subunit and Glycoconjugate Vaccines and Their Potential to Elicit Cross-Protection to Burkholderia cepacia Complex

  2024cites this paper
• Bacterial Colonization of the Lower Airways in Children With Esophageal Atresia

  2023cites this paper
• [68Ga]Ga-Ornibactin for Burkholderia cepacia complex Infection Imaging Using Positron Emission Tomography

  2023cites this paper
• Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development

  2023cites this paper
• Preclinical testing of antimicrobials for cystic fibrosis lung infections: current needs and future priorities

  2023cites this paper
• Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials

  2023cites this paper
• Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant Pseudomonas aeruginosa.

  2023cites this paper
• The effect of layer charge origin and density, type of interlayer cations, and occupancy of the octahedral sheet of smectites on the adsorption of pyocyanin

  2023cites this paper
• Establishment and characterization of a new Pseudomonas aeruginosa infection model using 2D airway organoids and dual RNA sequencing

  2023cites this paper
• The Burkholderia contaminans prevalent phenotypes as possible markers of poor clinical outcomes in chronic lung infection of children with cystic fibrosis.

  2023cites this paper
• Dot Immunobinding Assay for the Rapid Serodetection of Scedosporium/Lomentospora in Cystic Fibrosis Patients

  2023cites this paper
• Role of inhaled antibiotics in the era of highly effective CFTR modulators

  2023cites this paper
• Exposure of Aspergillus fumigatus to Klebsiella pneumoniae Culture Filtrate Inhibits Growth and Stimulates Gliotoxin Production

  2023cites this paper
• Radiometal chelators for infection diagnostics

  2023cites this paper
• Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment

  2023cites this paper
• Evaluation of the Efficiency of Random and Diblock Methacrylate-Based Amphiphilic Cationic Polymers against Major Bacterial Pathogens Associated with Cystic Fibrosis

  2023influential citation
• Prolonged Subculturing of Aspergillus fumigatus on Galleria Extract Agar Results in Altered Virulence and Sensitivity to Antifungal Agents

  2023cites this paper
• Improving Protection to Prevent Bacterial Infections: Preliminary Applications of Reverse Vaccinology against the Main Cystic Fibrosis Pathogens

  2023cites this paper
• Efficacy of Antibiotic Eradication Therapy of Early Pseudomonas aeruginosa Infection in Children with Primary Ciliary Dyskinesia.

  2023cites this paper
• Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis

  2023cites this paper
• Small-molecule activators of a bacterial signaling pathway inhibit virulence

  2023cites this paper
• Unique Presentations of Burkholderia gladioli Infections in Several Strains of Immunocompromised Mice.

  2023cites this paper
• Neutrophil bactericidal activity and host defenses in cystic fibrosis: a narrative review

  2023cites this paper
• The first study characterizing the respiratory microbiome in cystic fibrosis patients in Jordan

  2023cites this paper
• Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.

  2023cites this paper
• Virtual Screening of Potential RoxS Inhibitors and Evaluation of Their Antimicrobial Activity in Combination with Antibiotics against Clinically Resistant Bacteria

  2023cites this paper
• NaCl-induced modulation of species distribution in a mixed P. aeruginosa / S. aureus /B.cepacia biofilm

  2023cites this paper
• Longitudinal bacterial prevalence in cystic fibrosis airways: Fact and artifact.

  2023cites this paper
• Loss of CFTR function in macrophages alters the cell transcriptional program and delays lung resolution of inflammation

  2023cites this paper
• Breath of fresh insight: unraveling the evolution of our understanding of cystic fibrosis pulmonary exacerbations

  2023cites this paper
• Analysis of Pseudomonas aeruginosa transcription in an ex vivo cystic fibrosis sputum model identifies metal restriction as a gene expression stimulus

  2023cites this paper
• Polyyne-producing Burkholderia suppress Globisporangium ultimum damping-off disease of Pisum sativum (pea)

  2023cites this paper
• Application of nanomaterials as potential quorum quenchers for disease: Recent advances and challenges.

  2023cites this paper
• Exploring Antibiotic-Potentiating Effects of Tobramycin–Deferiprone Conjugates in Pseudomonas aeruginosa

  2023cites this paper
• Analysis of blood microbiome dysbiosis in pulmonary sarcoidosis by decision tree model

  2023cites this paper
• Antibacterial Activity of a Natural Clay Mineral against Burkholderia cepacia Complex and Other Bacterial Pathogens Isolated from People with Cystic Fibrosis

  2023cites this paper
• Identification of two distinct phylogenomic lineages and model strains for the understudied cystic fibrosis lung pathogen Burkholderia multivorans

  2023influential citation
• Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future

  2023cites this paper
• Updated Review on Nocardia Species: 2006–2021

  2022cites this paper
• Antimicrobial susceptibility and genotyping of microorganisms isolated from sputum culture of children with cystic fibrosis in an Iranian referral children’s hospital

  2022cites this paper